Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
FranceStudy on the Long-Term Safety of Alpelisib for Patients with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
FranceStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
FranceStudy on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy
FranceStudy of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer
FranceStudy on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer
FranceStudy on Lasmiditan for Treating Migraine in Children Aged 6 to 17
FranceComparing drug combinations with panitumumab for patients with RAS and B-RAF wild-type metastatic colorectal cancer
FranceSafety and Tolerability Study of AB-1001 Brain Injection in Adults with Early Huntington's Disease
FranceStudy on Baricitinib for Treating Large Inflammatory Liver Adenomas in Women and Non-Resectable Cases in Men
FranceStudy of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
